Lycopene inhibits LPS-induced proinflammatory mediator inducible nitric oxide synthase in mouse macrophage cells

Journal of Food Science

Volumn 72, Issue 1, 2007, Pages S069-S074

  Rafi, Mohamed M ^a   Yadav, Prem Narayan ^a   Reyes, Marynell ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

COX 2; Inflammation; iNOS; Lycopene; Macrophages

Indexed keywords

CARICA PAPAYA; CITRULLUS LANATUS VAR. LANATUS; CITRUS X PARADISI; LYCOPERSICON ESCULENTUM; PRUNUS ARMENIACA; PSIDIUM;

CAROTENOID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LYCOPENE; MESSENGER RNA; NITRIC OXIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; MACROPHAGE; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAROTENOIDS; CELL LINE; CYCLOOXYGENASE 2; DRUG ANTAGONISM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33846968424     PISSN: 00221147     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2006.00219.x     Document Type: Article

References (49)

1. Bai SK, Lee SJ, Na HJ, Ha KS, Han JA, Lee H, Kwon YG, Chung CK, Kim YM. 2005. B-carotene inhibits inflammatory gene expression in lipopolysaccharide- stimulated macrophages by suppressing redox-based NJ-κ B activation. Exp Mol Med 37:323-34.
2. Barnes PJ, Karin M. 1997. Nuclear factor-κ B - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-71.
3. Bor JY, Chen HY, Yen GC. 2006. Evaluation of antioxidant activity and inhibitory effect on nitric oxide production of some common vegetables. J Agric Food Chem 54:1680-6.
4. Burrie BJ. 1997. Beta-carotene and human health: a review of current research. Nutr Res 17:547-80.
5. Byers T, Perry G. 1992. Dietary carotenoids, vitamin C and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 12:139-59.
6. Chen JC, Ho FM, Chao PDL, Chen CP, Jeng KCG, Hsu HB, Lee ST, Wu WT, Lin WW. 2005. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of Iκ B kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol 521:9-20.
7. Chew BP. 1993. Role of carotenoids in the immune response. J Dairy Sci 76(9):2804-11.
8. Chew BP, Wong MW, Wong TS. 1996. Effects of lutein from marigold extract on immunity and growth of mammary tumors in mice. Anticancer Res 16(6B):3689-94.
9. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW Jr. 1996. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5(10):823-33.
10. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. 2001. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166(6):3873-81.
11. Di Mascio P, Kaiser S, Sies H. 1989. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274:532-8.
12. Di Mascio P, Devasagayam TP, Kaiser S, Sies H. 1990. Carotenoids, tocopherols and thiols as biological singlet molecular oxygen quenchers. Biochem Soc Trans 18(6): 1054-6.
13. Epe B, Ballmaier D, Roussyn I, Briviba K, Sies H. 1996. DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Res 24:4105-10.
14. Gartner C, Stahl W, Sies H. 1997. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 66(1):116-22.
15. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. 1995. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87:1767-76.
16. Heber D, Lu QY. 2002. Overview of mechanisms of action of lycopene. Exp Biol Med 227:920-3.
17. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. 1996. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145-9.
18. Hobbs AJ, Higgs A, Moncada S, 1999. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39:191-220.
19. Hussain T, Gupta S, Mukhtar H. 2003. Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 191:125-35.
20. Ito Y, Wakai K, Suzuki K, Tamakoshi A, Seki N, Ando M, Nishino Y, Kondo T, Watanabe Y, Ozasa K, Ohno Y. 2003. Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) study. Cancer Sci 94(1):57-63.
21. Jyonouchi H, Zhang L, Tomita Y. 1993. Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr Cancer 19(3):269-80.
22. Kim L, Rao AV, Rao LG. 2002. Effect of lycopene on prostate LNCaP cancer cells in culture. J Med Food 5(4):181-7.
23. Klein E. 2005. Chemoprevention of prostate cancer. Crit Rev Oncol Hematol 54:1-10.
24. Krinsky NI. 2002. Possible biological mechanisms for a protective role of xanthophylls. J Nutr 132:540-2.
25. Krinsky NI, Johnson EJ. 2005. Carotenoid actions and their relation to health and disease. Mol Aspects Med 26:459-516.
26. Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. 1996. Intake of vitamins A, C and E and postmenopausal breast cancer. Am J Epidemiol 144:165-74.
27. Lahti A, Lahde M, Kankaanranta H, Moilanen E. 2000. Inhibition of extracellular signal-regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells. J Pharmacol Exp Ther 294:1188-94.
28. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y. 1995. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 24(3):257-66.
29. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20:1945-52.
30. Liao CH, Sang S, Liang YC, Ho CT, Lin JK. 2004. Suppression of inducible nitric oxide synthase and cyclooxygenase-2 in downregulating nuclear factor-kappa B pathway by garcinol. Mol Carcinog 41:140-9.
31. Livny O, Kaplan I, Reifen R, Polak-Charcon S, Madar Z, Schwartz B. 2002. Lycopene inhibit proliferation and enhances gap-junction communication of κB-1 human oral tumor cells. J Nutr 132(12):3754-9.
32. Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. 2002. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-κ B in mouse macrophages. Carcinogenesis 23:983-91.
33. Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE. 2002, The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview J Nutr 132:518-24.
34. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, al-Saffar N, Revell PA, Moncada S. 1997. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 150:881-7.
35. Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT. 1993. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 193(1):398-405.
36. Palozza P, Serini S, Torsello A, Di Nicuolo F, Piccioni E, Ubaldi V, Pioli C, Wolf FI, Calviello G. 2003. Beta-carotene regulates NF-kappaB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J Nutr 133(2):381-8.
37. Palozza P, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti F, Calviello G. 2005. B-carotene down regulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells. Am Soc Nutr Sci 135:129-36.
38. Park JS, Boon PC, Wong TS, Zhang J, Magnuson NS. 1999. Dietary lutein but not astaxanthin or β-carotene increases pim-1 gene expression in murine lymphocytes. Nutr Cancer 33(2):206-12.
39. Pruthi RS, Wallen EM. 2005. Cyclooxygenase-2: a therapeutic target for prostate cancer. Clin Genitourin Cancer 4:203-11.
40. Rock CL, Saxe GA, Ruffin MT 4th, August DA, Schottenfeld D. 1996. Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutr Cancer 25(3):281-96.
41. Rock CL, Thornquist MD, Neuhouse ML, Kristal AR, Neumark-Sztainer D, Cooper DA, Patterson RE, Cheskin LJ. 2002. Diet and lifestyle correlates of lutein in the blood and diet. J Nutr 132:5255-30.
42. Sautebin L. 2000. Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. Fitoterapia 71:S48-S5.
43. 2 production. Eur J Pharmacol 447:187-94.
44. Snodderly DM. 1995. Evidence of protection against age related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62:1448s-61.
45. Stahl W, Sies H. 1992. Uptake of lycopene and its geometrical isomers is greater from heat processed than from unprocessed tomato juice in humans. J Nutr 122(11):2161-6.
46. Stahl W, Junghans A, de Boer B, Driomina ES, Briviba K, Sies H. 1998. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 427(2):305-8.
47. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. 1995. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 114:1335-42.
48. Szabo C, Wu CC, Mitchell JA, Gross SS, Thiemermann C, Vane JR. 1993. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 7:991-9.
49. Ziegler RG. 1989. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 19:116-22.